Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Аллергический ринит

Список литературы

  1. Аллергология и иммунология: национальное руководство / Под ред. Хаитова РМ, Ильиной НИ. - М. : ГЭОТАР-Медиа, 2009:656.
  2. Ильина НИ, Курбачева ОМ, Павлова КС, Польнер СА. Федеральные клинические рекомендации: Аллергический ринит. РАЖ. 2017;(2):47-54.
  3. Хаитов МР, Намазова-Баранова ЛС, Чучалин АГ, Дайхес НА, Ильина НИ, Курбачева ОМ, Agache I, Bachert C, Bedbrook A, Canonica GW, Casale T, Cruz AA, Fokkens WJ, Hellings PW, Samolinski B, Bousquet J. ARIA 2016: Современные направления оказания медицинской помощи больным аллергическим ринитом в свете требований прецизионной медицины. РАЖ. 2017;(3):46-54.
  4. Brozek JL, Bousquet J, Baena-Cagnani CE et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2017 revision. J. Allergy Clin. Immunol. 2017; 140(4). DOI: 10/1016/j/jaci.2017.03.050
  5. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008; 63: 8-160.
  6. Хаитов М.Р., Намазова-Баранова Л.С., Ильина Н.И., Курбачёва О.М., Bachert C., Hellings P.W., Pfaar O., Schunemann H.J., Wallace D., Bedbrook A., Czarlewski W., Bousquet J. ARIA 2019: алгоритмы оказания помощи при аллергическом рините в России. РАЖ. 2020;17(1):7-22
  7. Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, Azar A, Baroody FM, Bachert C, Canonica GW, Chacko T, Cingi C, Ciprandi G, Corey J, Cox LS, Creticos PS, Custovic A, Damask C, DeConde A, DelGaudio JM, Ebert CS, Eloy JA, Flanagan CE, Fokkens WJ, Franzese C, Gosepath J, Halderman A, Hamilton RG, Hoffman HJ, Hohlfeld JM, Houser SM, Hwang PH, Incorvaia C, Jarvis D, Khalid AN, Kilpeläinen M, Kingdom TT, Krouse H, Larenas‐Linnemann D, Laury AM, Lee SE, Levy JM, Luong AU, Marple BF, McCoul ED, McMains KC, Melén E, Mims JW, Moscato G, Mullol J, Nelson HS, Patadia M, Pawankar R, Pfaar O, Platt MP, Reisacher W, Rondón C, Rudmik L, Ryan M, Sastre J, Schlosser RJ, Settipane RA, Hemant P. Sharma HP, Sheikh A, Smith TL, Tantilipikorn P, Tversky JR, Veling MC, Wang DY, Westman M, Wickman M, Zacharek M. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis - Int Forum Allergy Rhinol. 2018;8: 85–107. First published:13 February 2018 https://doi.org/10.1002/alr.22073
  8. Global atlas of allergy. Editors: Cezmi A. Akdis, Ioana Agache. Published by the European Academy of Allergy and Clinical Immunology. 2014; 388.
  9. Гущин ИС. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт, 1998.
  10. Ильина Н.И., Курбачева О.М., Павлова К.С., Ильина Е.В. Скрининговое эпидемиологическое исследование (GA2LEN) по выявлению аллергических заболеваний и заболеваний органов дыхания в России. РАЖ 2009; 3: 1.
  11. Ильина Н. И., Лусс Л. В., Курбачева О. М., Назарова Е. В., Павлова К. С. Влияние климатических факторов на спектр и структуру аллергических заболеваний на примере Московского региона. РАЖ. 2014. № 2. С. 25-31.
  12. Хаитов Р.М., Ильина Н.И., Курбачева О.М., Павлова К.С. Традиции, достижения и инновации в современной аллергологии. Физиология и патология иммунной системы. Иммунофармакогеномика, 2010, том 14, №1, стр. 3-14.
  13. Asher M.I., Weiland S.K. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Streering Committee. Clin. Exp. Allergy. 1998. 28 (suppl. 5). P. 52—66.
  14. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24:758–764.
  15. Van Cauwenberge PB, Ciprandi G, Vermeiren JS. J. Epidemiology of allergic rhinitis. The UCB Institute of Allergy. 2001; 27.
  16. Pawankar R, Canonica GW, Holgate ST et al. The World Allergy Organization White Book on Allergy. 2013.
  17. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol. 1998;101(2 Pt 2):S352-6.
  18. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992;90(4 Pt 1):579-88
  19. Greisner Wr, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19(4):185-8.
  20. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult- onset asthma. J Allergy Clin Immunol 2002;109(3):419-25.
  21. Tohidinik HR, Mallah N, Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis. World Allergy Organ J. 2019;12(10):100069. Published 2019 Oct 17. doi:10.1016/j.waojou.2019.100069
  22. Vignola AM, Chanez P, Godard P, Bousquet J. Relationships between rhinitis and asthma. Allergy 1998;53(9):833-9.
  23. Rondón C1, Campo P, Togias A, Fokkens WJ, Durham SR, Powe DG, Mullol J, Blanca M. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012 Jun;129(6):1460-7. doi: 10.1016/j.jaci.2012.02.032. Epub 2012 Apr 18.
  24. Курбачева ОМ, Павлова КС. Аллергический ринит и аллергический конъюнктивит: одна болезнь - две клинические формы. Российский аллергологический журнал. 2015;(3):22-29.
  25. Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulmonary Medicine. 2006;6(Suppl 1):S4. DOI:10.1186/1471-2466-6-S1-S4.
  26. Poorey VK, Soni S, Thakur P, Gupta A. Effect of Nasal Allergy Over Spirometric Parameters: A Prospective Study. Indian J Otolaryngol Head Neck Surg. 2016;68(1):6-10. doi:10.1007/s12070- 015-0876-x
  27. Togias A. Unique mechanistic features of allergic rhinitis. J. Allergy Clin. Immunol. 2000; 105:S599-S604.
  28. Курбачева ОМ, Павлова КС, Галицкая МА. Аллерген-специфическая иммунотерапия. Аналитический обзор современных международных и отечественных позиционных документов. Российский аллергологический журнал. 2017; 1:24-32.
  29. Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 2011:Jan;127(1):30-8. DOI: 10.1016/j.jaci.2010.08.024. Epub 2010 Oct 20.
  30. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10 year follow-up on the PAT study. Allergy. 2007;62(8):943–948.
  31. Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O’Hehir R, Kleine-Tebbe J, Muraro A, Lack G, Larenas D, Levin M, Nelson H, Pawankar R, Pfaar O, van Ree R, Sampson H, Santos AF, Du Toit G, Werfel T, Gerth van Wijk R, Zhang L, Akdis CA. Internetional Consensus On (ICON) Allergy Immunotherapy (AIT) J Allergy Clin Immunol. 2015 Sep;136(3):556-68
  32. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J. Allergy Clin. Immunol. 2002;109(2):251–256.
  33. Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006;61(7):855–859.
  34. Papadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976–997.
  35. Zielen S, Devillier P, Heinrich J, Richter H, Wahn U. Sublingual immunotherapy provides long- term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy. 2018;73(1):165–177. Multiple regression analysis on data from real- world database demonstrates the long-term effect of SLIT and the preventive effect of SLIT on asthma onset and progression in patients with allergic rhinitis.
  36. Bousquet P.J., Combescure C., Neukirch F., Klossek J.M., Méchin H., Daures J.P. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007; 62 (4): 367–372. DOI: 10.1111/j.1398-9995.2006.01276.x.
  37. Bousquet J, Schunemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367-74 e2.
  38. Courbis AL, Murray RB, Arnavielhe S, Caimmi D, Bedbrook A, Van Eerd M, et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48(12):1640-53.
  39. Тюфилин Д.С., Деев И.А., Кобякова О.С., Куликов Е.С., Табакаев Н.А., Винокурова Д.А., Кириллова Н.А. Контроль аллергического ринита: современные инструменты оценки. Бюллетень сибирской медицины. 2019; 18 (2): 262–273. https://doi.org: 10.20538/1682-0363- 2019-2-262–273.
  40. Papadopoulos NG, Bernstein JA, Demoly P, Dykewicz M, Fokkens W, Hellings PW, Peters AT, Rondon C, Togias A, Cox LS. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015 May;70(5):474-94. DOI: 10.1111/all.12573. Epub 2015 Feb 19.
  41. Droste JH, Kerhof M, de Monchy JG, Schouten JP, Rijcken B. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group. J Allergy Clin Immunol 1996;97:922-32.
  42. Di Lorenzo G, Pacor ML, Amodio E, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol. 2011;155:263–270.
  43. Gelardi M, Passalacqua G, Fiorella ML, Quaranta N. Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations. Eur Ann Allergy Clin Immunol. 2013;45:25–29.
  44. Gelardi M, Peroni DG, Incorvaia C, et al. Seasonal changes in nasal cytology in mite‐allergic patients. J Inflamm Res. 2014;7:39–44.
  45. Park SC, Kim JH, Lee KH, Hong SC, Lee HS, Kang JW. Association of serum eosinophilia and total immunoglobulin E concentration with the risk of allergic symptoms and allergic sensitization, respectively: A 2‐year follow‐up study. Int J Pediatr Otorhinolaryngol. 2016;86:167–171.
  46. Tay TR, Bosco J, Aumann H, O"Hehir R, Hew M. Elevated total serum immunoglobulin E (≥1000 IU/mL): implications? Intern Med J. 2016;46:846–849.
  47. Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc. 2009;59:698–702.
  48. Tu YL, Chang SW, Tsai HJ, et al. Total serum IgE in a population‐based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy. PLoS One. 2013;8:e80996.
  49. Ameli F, Brocchetti F, Tosca MA, Signori A, Ciprandi G. Nasal endoscopy in children with suspected allergic rhinitis. Laryngoscope. 2011;121:2055–2059.
  50. Eren E, Aktas A, Arslanoglu S, et al. Diagnosis of allergic rhinitis: inter‐rater reliability and predictive value of nasal endoscopic examination: a prospective observational study. Clin Otolaryngol. 2013;38:481–486.
  51. Jareoncharsri P, Thitadilok V, Bunnag C, Ungkanont K, Voraprayoon S, Tansuriyawong P. Nasal endoscopic findings in patients with perennial allergic rhinitis. Asian Pac J Allergy Immunol. 1999;17:261–267.
  52. Brunner JP, Jawad BA, McCoul ED. Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities. Otolaryngol Head Neck Surg. 2017;157:519–523.
  53. Tschopp JM, Sistek D, Schindler C, et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss Study on Air Pollution and Lung Diseases in Adults. Allergy. 1998;53:608–613.
  54. Nevis IF, Binkley K, Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016 Apr 27;12:20. DOI: 10.1186/s13223-016-0126-0. eCollection 2016.
  55. Health Quality Ontario. Skin Testing for Allergic Rhinitis: A Health Technology Assessment. Ont Health Technol Assess Ser. 2016;16(10):1‐45. Published 2016 May 1.
  56. Nevis1IF, Binkley K., Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016,12:20 DOI 10.1186/s13223-016-0126-0.
  57. Liu CY, Zhang Y, Han DM, Zhang L. Evaluation of serum specific IgE for the diagnosis of allergic rhinitis with multi-allergens. Chin Med J (Engl). 2010;123(20):2836‐2841.
  58. Jiang XD, Li GY, Dong Z, Zhu DD. Correlation analysis of two serum-specific immunoglobulin E test systems and skin-prick test in allergic rhinitis patients from northeast China. Am J Rhinol Allergy. 2011;25(2):116‐119. doi:10.2500/ajra.2011.25.3572.
  59. Cox L. Overview of serological-specific IgE antibody testing in children. Curr Allergy Asthma Rep. 2011;11(6):447‐453. doi:10.1007/s11882-011-0226-3.
  60. Hamilton RG, Oppenheimer J. Serological IgE Analyses in the Diagnostic Algorithm for Allergic Disease [published correction appears in J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):374]. J Allergy Clin Immunol Pract. 2015;3(6):833‐842. doi:10.1016/j.jaip.2015.08.016.
  61. Steering Committee Authors; Review Panel Members. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020. World Allergy Organ J. 2020;13(2):100091. Published 2020 Mar 7. doi:10.1016/j.waojou.2019.100091
  62. Ferrer M, Sanz ML, Sastre J, Bartra J, A del Cuvillo, Montoro J, Jáuregui I, Dávila I, Mullol J, Valero A. Molecular diagnosis in Allergology: application of the microarray technique. J Investig Allergol Clin Immunol. 2009; 19(1): 19-24.
  63. Akdis CA, Jutel M, Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem Immunol Allergy. 2008;94:67– 82.
  64. Allocco FT, Votypka V, De Tineo M, Naclerio RM, Baroody FM. Effects of fexofenadine on the early response to nasal allergen challenge. Annals of allergy, asthma & immunology. 2002;89(6):578‐584.
  65. Benninger M, Farrar JR, Blaiss M, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104:13e29.
  66. Berger WE, Lumry WR, Meltzer EO, Pearlman DS: Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. Allergy Asthma Proc. 2006, 27 (3): 214-223. DOI: 10.2500/aap.2006.27.2851.
  67. Bocsan CI, Bujor AI, Miron N, Vesa SC, Deleanu D, Buzoianu AD. In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial. Balkan medical journal, 2015, 32(4), 352‐358. DOI:10.5152/balkanmedj.2015.15884
  68. Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, et al. ACCEPT-1 Study Group. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64:1516 –1523.
  69. Canonica GW, Tarantini F, Compalati E, Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy. 2007;62:359 –366.
  70. De Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatric allergy and immunology, 2005, 16(3): 267‐275.
  71. Dykewicz MS, Wallace DV, Baroody F, Bernstein J, Craig T, Finegold I, Huang F, Larenas-Linnemann D, Meltzer E, Steven G, Bernstein DI, Blessing-Moore J, Dinakar C, Greenhawt M, Horner CC, Khan DA, Lang D, Oppenheimer J, Portnoy JM, Randolph CR, Rank MA; Workgroup Chair and Cochair, Dykewicz MS, Wallace DV. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017 Dec;119(6):489-511.e41. doi: 10.1016/j.anai.2017.08.012. Epub 2017 Nov 2.
  72. Farré M, Pérez-Mañá C, Papaseit E, et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers. Br J Clin Pharmacol. 2014;78(5):970‐980. DOI:10.1111/bcp.12421.
  73. Gillman S, Gillard M, Strolin Benedetti M: The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines. Allergy Asthma Proc. 2009; 30 (4): 366-376. DOI:10.2500/aap.2009.30.3226.
  74. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy. 2002;32:489–498.
  75. Lukat K, Rivas P, Roger A, Kowalski M, Botzen U, Wessel F. A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study. Journal of asthma and allergy, 2013(6):31‐39.
  76. Mösges R, König V, Köberlein J. The effectiveness of modern antihistamines for treatment of allergic rhinitis - an IPD meta-analysis of 140,853 patients. Allergol Int. 2013;62(2):215‐222. DOI:10.2332/allergolint.12-OA-0486
  77. Muntean A, Bocsan I, Deleanu, DM. The effect of H1-antihistamines on allergic inflammation in patients with allergic rhinitis. Human and Veterinary Medicine; Cluj-Napoca. 2016, 8(4):161- 165.
  78. Naclerio RM. The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngology--head and neck surgery. 1993,108(6):723‐730.
  79. Okubo K, Suzuki T, Tanaka A, Aoki H. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial. Allergology international, 2019, 68(2):207‐215
  80. Valk P, Jetten A, Simons R, Valiente R, Labeaga L. Effects of a single oral dose of bilastine 20 mg on flying ability in healthy volunteers under conditions of simulated cabin pressure. Allergy: european journal of allergy and clinical immunology, 2015 (70):647.
  81. Ильина Н.И., Павлова К.С. Антигистминные, противовоспалительные и противоаллергические свойства дезлоратадина. Consilium Medicum. 2015; 3: 79-83.
  82. Church MK, Maurer M, Simons FE, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65:459e466.
  83. Simons FE: Advances in H1-antihistamines. N Engl J Med. 2004, 351 (21): 2203-2217. DOI: 10.1056/NEJMra033121.
  84. Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara‐Blanco A. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No.: CD009566. DOI: 10.1002/14651858.CD009566.pub2.
  85. Lee TA, Pickard AS. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. Pharmacotherapy. 2007;27(6):852‐859. doi:10.1592/phco.27.6.852
  86. Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD003163. DOI: 10.1002/14651858.CD003163.pub4.
  87. Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J Allergy Clin Immunol. 2001;108:S54-S58.
  88. Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol. 2007;21:70-79.
  89. Penagos M, Compalati E, Tarantini F, Baena-Cagnani CE, Passalacqua G, Canonica GW. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis: meta-analysis of randomized, double-blind, placebocontrolled, clinical trials. Allergy. 2008;63:1280-1291.
  90. Rodrigo GJ, Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy. 2011;41:160-170.
  91. Wu EL, Harris WC, Babcock CM, Alexander BH, Riley CA, McCoul ED. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2019;161(1):18‐27. doi:10.1177/0194599819832277
  92. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479–84.
  93. Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. Curr Med Res Opin. 2008;24(6):1833-40.
  94. DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;24:331-337.
  95. Bielory L, Chun Y, Bielory BP, Canonica GW. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy. 2011;66:686-693.
  96. Bousquet J, Meltzer EO, Couroux P, Koltun A, Kopietz F, Munzel U, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-32.
  97. Debbaneh PM, Bareiss AK, Wise SK, McCoul ED. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2019;161(3):412‐418. doi:10.1177/0194599819841883
  98. Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105:168-173.
  99. Chunhui Wei. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis C. Biomedicine & Pharmacotherapy. 2016; (83): 989–997.
  100. Lu Y, Yin M, Cheng L. Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014; 49(8):659- 67.
  101. Modgill V, Badyal DK, Verghese A. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Methods Findings Exp Clin Pharmacol. 2010;32: 669-674.
  102. Ngamphaiboon J. Montelukast in general pediatric practices. J Med Assoc Thai. 2005;88:S348- S351.
  103. Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Khattiyawittayakun L, Snidvongs K. Leukotriene Receptor Antagonist Addition to H1-Antihistamine Is Effective for Treating Allergic Rhinitis: A Systematic Review and Meta-analysis. Am J Rhinol Allergy. 2019;33(5):591‐600. doi:10.1177/1945892419844459
  104. Xu Y, Zhang J, Wang J. The Efficacy and Safety of Selective H1-Antihistamine versus Leukotriene Receptor Antagonist for Seasonal Allergic Rhinitis: A Meta-Analysis. 2014; PLOS ONE 9(11): e112815.
  105. Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother. 2004;5:679-686.
  106. Polos PG. Montelukast is an effective monotherapy for mild asthma and for asthma with co- morbid allergic rhinitis. Prim Care Respir J. 2006;15:310e311. author reply 1e2.
  107. Watts K, Chavasse RJPG. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD006100. DOI: 10.1002/14651858.CD006100.pub2.
  108. Khattiyawittayakun L, Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Snidvongs K. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018;8(12):1445‐1453. doi:10.1002/alr.22193
  109. Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997;107(1):40–3.
  110. Okubo K. et al. Efficacy of Omalizumab for Severe Allergic Rhinitis Induced By Japanese Cedar Pollen in Patients Treated with Combination Oral Antihistamines and Nasal Corticosteroids. Journal of Allergy and Clinical Immunology. 2019; 143(2): AB424;
  111. Okubo K, et al. Poster presented at The EAACI. June 1-6, 2019, Lisbon,Poster#L1372
  112. Tsabouri S. et al. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. The Journal of Allergy and Clinical Immunology: In Practice. 2014; 2(3):332-340.
  113. Yu C, Wang K, Cui X, et al. Clinical Efficacy and Safety of Omalizumab in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Am J Rhinol Allergy. 2020;34(2):196‐208. doi:10.1177/1945892419884774
  114. Kilburn SA, Lasserson TJ, McKean MC. Pet allergen control measures for allergic asthma in children and adults. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD002989. DOI: 10.1002/14651858.CD002989.
  115. Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD001563. DOI: 10.1002/14651858.CD001563.pub3.
  116. Head K, Snidvongs K, Glew S, Scadding G, Schilder AGM, Philpott C, Hopkins C. Saline irrigation for allergic rhinitis. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD012597. DOI: 10.1002/14651858.CD012597.pub2
  117. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mösges R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2012;26(5):e119‐e125. doi:10.2500/ajra.2012.26.3787
  118. Li CL, Lin HC, Lin CY, Hsu TF. Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis. J Clin Med. 2019;8(1):64. Published 2019 Jan 9. doi:10.3390/jcm8010064
  119. Valerieva A, Church MK, Staevska M, Kralimarkova T, Petkova E, Nedeva D, Valerieva E, Lazarova T, Dimitrov V, Popov TA. Micronized cellulose powder as a means to enhance intranasal symptoms-driven treatment: patients" attitudes in a real life setting. Allergy, 2016 (71):13.
  120. Курбачева ОМ, Павлова КС. Федеральные клинические рекомендации. Аллерген- специфическая иммунотерапия. Российский Аллергологический Журнал. 2006 (4–5): 55-6.
  121. Des Roches A., Paradis L., Menardo J.L., Bouges S., Daures J.P., Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J. Allergy Clin. Immunol. 1997; 99: 450-453.
  122. Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017;72(11):1597‐1631. doi:10.1111/all.13201
  123. Feng B, Wu J, Chen B, et al. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: A meta-analysis of randomized controlled trials. Am J Rhinol Allergy. 2017;31(1):27‐35. doi:10.2500/ajra.2017.31.4382
  124. Kim J.M., Lin S.Y., Suarez-Cuervo C. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013; 131: 1155-1167.
  125. Li Y, Yu SY, Tang R, Zhao ZT, Sun JL. Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials. Chin Med J (Engl). 2018;131(21):2583‐2588. doi:10.4103/0366-6999.244108
  126. Mösges R, Santiago V, A, Allekotte, S. et al. Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis. Clin Transl Allergy. 2019: 9; 29. DOI: 10.1186/s13601-019-0268-5
  127. Purello-D’Ambrosio F., Gangemi S., Merendino R.A. et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin. Exp. Allergy. 2001; 31: 1295-1302.
  128. Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD002893. DOI: 10.1002/14651858.CD002893.pub2.
  129. Tahamiler R., Saritzali G., Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007; 117: 965-969.
  130. Wilson DR., Lima MT., Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005; 60: 4-12.
  131. Курбачева ОМ, Павлова КС, Галицкая МА, Смирнов ДС. Актуальные представления о механизмах аллерген- специфической иммунотерапии, потенциальных маркерах эффективности и путях совершенствования. Российский аллергологический журнал. Журнал. 2017; (4-5): 5-17.
  132. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;(133):621-631. DOI: 10.1016/j.jaci.2013.12.1088.
  133. Pfaar O, Demoly P, Gerth van Wijk R, Bonini S, Bousquet J, Canonica GW, Durham SR, Jacobsen L, Malling HJ, Mosges R, Papadopoulos NG, Rak S, Rodriguez del Rio P, Valovirta E, Wahn U, Calderon MA. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014; 69: 854–867.
  134. Mishra A, Kawatra R, Gola M. Interventions for atrophic rhinitis. Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD008280. DOI: 10.1002/14651858.CD008280.pub2.
  135. Jose J, Coatesworth AP. Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment. Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD005235. DOI: 10.1002/14651858.CD005235.pub2.
  136. Feng S, Han M, Fan Y, Yang G, Liao Z, Liao W, et al. Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2015; 29(1):57-62. DOI: 10.2500/ajra.2015.29.4116
  137. Zhang J, Zhang Y, Huang X, et al. Different Acupuncture Therapies for Allergic Rhinitis: Overview of Systematic Reviews and Network Meta-Analysis. Evid Based Complement Alternat Med. 2020;2020:8363027. Published 2020 Apr 23. doi:10.1155/2020/8363027
  138. Ant K., Pearce N., Anderson H.R., Ellwood P., Montefort S., Shah J. Global map of the prevalence of symptoms of rhino-conjunctivitis in children. The International Study of Asthma and Allergies in Childhood ISAAC Phase Three. Allergy. 2009; 64: 123-148.
  139. Maspero JF, Rosenblut A, Finn A Jr, Lim J, Wu W, Philpot E. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol Head Neck Surg. 2008;138:30-37
  140. Nasser M, Fedorowicz Z, Aljufairi H, McKerrow W. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD006989. DOI: 10.1002/14651858.CD006989.pub2.
  141. Roberts G, Xatzipsalti M, Borrego LM, Custovic A, Halken S, Hellings PW, Papadopoulos NG, Rotiroti G, Scadding G, Timmermans F, Valovirta E. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013; 68: 1102-1116.
  142. РАДАР. Аллергический ринит у детей: рекомендации и алгоритм при детском аллергическом рините. 2-е изд., перераб. и доп. М.: Оригинал-макет, 2017.
  143. Лопатин АС. Диагностика и лечение ринита и риносинусита у беременных. Российский аллергологический журнал. 2006: (1); 12-18.
  144. Gani F, Braida A, Lombardi C. et al. Rhinitis in pregnancy. Allerg. Immunol. (Paris). 2003; 35(8): 306- 313.
  145. Курбачева ОМ, Швец СМ. Аллергический ринит и беременность: возможности современной терапии. Эффективная фармакотерапия;2013 (18): 74-80.
  146. Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf. 2005;28(8):707‐719. doi:10.2165/00002018- 200528080-00005
  147. Yawn B, Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J Am Board Fam Pract. 2007; 20:289–298 DOI: 10.3122/jabfm.2007.03.060144
  148. Cetirizine Pregnancy and Breastfeeding Warnings. www.drugs.com/stats/top100/2013/q4/sales
  149. Kallen B, Otterblad Olausson P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol. 2007; 63 (4):383–388.

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*